markets

Baker Hughes Proposes Fixes to Push Through $13.6B Chart Deal

Baker Hughes is offering unspecified remedies to regulators in hopes of clearing its $13.6 billion acquisition of Chart Industries.

When a mega-merger runs into regulatory headwinds, companies typically have two options: walk away or start making concessions. Baker Hughes appears to be firmly in the second camp, offering unspecified remedies to smooth the path for its proposed $13.6 billion deal to acquire Chart Industries.

The details of what Baker Hughes is actually putting on the table remain vague — hence the word "unspecified" doing a lot of heavy lifting here. In merger-speak, remedies usually mean things like agreeing to sell off certain business units, licensing technology to competitors, or accepting behavioral conditions that limit how the combined company can operate. Any of those could satisfy antitrust watchdogs worried about reduced competition in the industrial equipment and energy technology space where both firms operate.

Read more Bitcoin Climbs to $65.5K as Iran Deal Pushes Oil to 16-Week Low →

For everyday investors, the uncertainty cuts both ways. On one hand, the fact that Baker Hughes is actively proposing fixes signals that both sides still want this deal to close. On the other hand, until those remedies are spelled out and accepted, there's real execution risk hanging over the transaction. A $13.6 billion deal is not small potatoes, and the terms of any required divestitures could meaningfully change the strategic value Baker Hughes originally saw in Chart Industries.

Chart Industries makes highly engineered equipment used in liquefied natural gas, industrial gases, and clean energy applications — areas that overlap significantly with Baker Hughes' own energy technology ambitions. That overlap is almost certainly what caught regulators' attention in the first place. Whether the remedies offered are enough to satisfy those concerns is the question investors and analysts will be watching closely in the weeks ahead.

Continue reading at SeekingAlpha.

Continue reading at SeekingAlpha →

Frequently Asked Questions

Q.What is the Baker Hughes and Chart Industries deal?

Baker Hughes has proposed acquiring Chart Industries in a deal valued at $13.6 billion. Chart Industries makes specialized equipment used in LNG, industrial gases, and clean energy applications.

Q.Why is Baker Hughes offering remedies for the Chart Industries acquisition?

Baker Hughes is offering remedies — likely concessions such as divestitures or behavioral commitments — to address regulatory concerns and secure antitrust approval for the deal.

Q.What kinds of remedies do companies typically offer in merger reviews?

In merger reviews, companies commonly offer to sell off overlapping business units, license technology to rivals, or accept operating restrictions — all aimed at convincing regulators that competition won't be harmed.

More in markets →